[The efficacy and safety of the patients of myelodysplastic syndromes-refractory anemia with excess blasts treated with decitabine alone or CAG/HAG regimen].
Zhonghua Xue Ye Xue Za Zhi
; 38(7): 572-577, 2017 Jul 14.
Article
in Zh
| MEDLINE
| ID: mdl-28810323
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Decitabine
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2017
Type:
Article
Affiliation country:
China